Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Spatial Convergent Clonal Evolution Leading to Ibrutinib Resistance and Disease Progression in Chronic Lymphocytic Leukemia

Richárd Kiss, Donát Alpár, PhD, Ambrus Gángó, MD, Noémi Nagy, Dora Aczel, Andras Matolcsy, MD PhD, Judit Csomor, Zoltán Mátrai, MD PhD, Csaba Bödör, PhD

Blood (2018) 132 (Supplement 1): 5539.

https://doi.org/10.1182/blood-2018-99-115937

Published: 2018

Journal Articles

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

Donát Alpár, PhD, Dóra Marosvári, MD, Richárd Kiss, Viktória Fésüs, Ambrus Gángó, MD, Noémi Nagy, Péter Farkas, MD, Szabolcs Tasnády, PhD, Marienn Réty, MD, Andras Matolcsy, MD PhD, Zoltán Mátrai, MD PhD, Csaba Bödör, PhD

Blood (2017) 130 (Supplement 1): 1457.

https://doi.org/10.1182/blood.V130.Suppl_1.1457.1457

Published: 2017

Journal Articles

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

Loránd L. Kis, Natalija Gerasimčik, Daniel Salamon, Emma K. Persson, Noémi Nagy, George Klein, Eva Severinson, Eva Klein

Blood (2011) 117 (1): 165–174.

https://doi.org/10.1182/blood-2010-01-265272

Published: 2011

Includes: Supplemental data

Journal Articles

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

Lorand L. Kis, Miki Takahara, Noemi Nagy, George Klein, Eva Klein

Blood (2006) 107 (7): 2928–2935.

https://doi.org/10.1182/blood-2005-06-2569

Published: 2006

Journal Articles

Nerve Growth Factor Released by CD40 Ligand-Transfected L Cells: Implications for Functional and Phenotypic Studies on CD40 + Cells

Angelo De Milito, Noemi Nagy, Astrid Samuelsson, Francesca Chiodi, Eva Rajnavölgyi

Blood (1998) 92 (11): 4482–4484.

https://doi.org/10.1182/blood.V92.11.4482

Published: 1998

NARROW

Spatial Convergent Clonal Evolution Leading to Ibrutinib Resistance and Disease Progression in Chronic Lymphocytic Leukemia

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

Nerve Growth Factor Released by CD40 Ligand-Transfected L Cells: Implications for Functional and Phenotypic Studies on CD40 + Cells

Email alerts

ASH Publications

American Society of Hematology

Spatial Convergent Clonal Evolution Leading to Ibrutinib Resistance and Disease Progression in Chronic Lymphocytic Leukemia

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

Nerve Growth Factor Released by CD40 Ligand-Transfected L Cells: Implications for Functional and Phenotypic Studies on CD40 + Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only